Meet us at AACR 2025 in Chicago
AACR Annual Meeting: The Epicenter of Oncology Innovation
The American Association for Cancer Research (AACR) Annual Meeting 2025 is the world's most comprehensive gathering focused on cancer science and medicine. It brings together the world's leading oncology researchers to share groundbreaking discoveries and technological innovations driving the field forward and creating an unparalleled forum for collaboration and knowledge exchange.
Single-Cell Analysis: Revealing Cancer's Hidden Complexities
Cancer's complexity demands analysis at the cellular level and its heterogeneity presents one of the greatest challenges in developing effective treatments. As cancer research grows intricate, automated solutions have become essential for accelerating discoveries, ensuring reproducibility, and handling massive datasets.
Single-cell analysis technologies have revolutionized cancer research by enabling scientists to:
Identify rare cell populations driving treatment resistance
Map cellular interactions within the tumor microenvironment
Track clonal evolution during disease progression
Monitor treatment response at unprecedented resolution
Discover novel biomarkers for early detection and prognosis
How Arralyze Technology Advances Cancer Research
Arralyze's CellShepherd platform and nanowell glass arrays provide cancer researchers with powerful tools to, analyze, characterize and even isolate individual immune cells that can kill cancer cells with unprecedented precision. Our technology offers several critical advantages:
1. High-Viability Cell Handling
Our gentle dispensing system maintains cellular integrity during isolation, preserving critical information about cell state and function that might otherwise be lost through harsh isolation methods. This capability is especially valuable when working with rare circulating tumor cells or limited patient samples.
2. Real-Time Monitoring of Cellular Interactions
The CellShepherd platform enables live imaging of cellular dynamics, allowing researchers to observe interactions between cancer cells and immune cells, monitor treatment responses over time, and identify cellular behaviors associated with e.g. metastatic potential.
3. Precise Single-Cell Retrieval
After identification and characterization, cells of interest can be retrieved non-destructively for downstream analysis, including sequencing, proteomics, or additional functional studies. This workflow integration streamlines the research process and maximizes the value of each sample.
4. High-Throughput Screening Capabilities
Our nanowell arrays accommodate thousands of cells on a compact footprint, enabling efficient screening of drug candidates against heterogeneous cancer cell populations. This approach accelerates the identification of compounds effective against specific cancer subtypes or resistant cell populations.
5. Automated Cell Analysis Systems
CellShepherd our automated cell analysis platform enables researchers to process thousands of samples with minimal hands-on time while maintaining exceptional data quality. These systems integrate seamlessly with existing laboratory equipment for comprehensive cancer cell analysis.
Visit ARRALYZE at AACR 2025
At Booth #536, our team will demonstrate how the CellShepherd platform can enhance your cancer research capabilities.
Whether you're investigating tumor heterogeneity or developing novel therapeutics come by and see how our technology can accelerate your research goals.
